NCT00545519View on ClinicalTrials.gov

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Relapsed Or Refractory Multiple Myeloma
Interventions
DRUG

thymoglobulin

Trial Locations (1)

63110

Washington Unvierstiy in St. Louis, St Louis

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00545519 - A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma | Biotech Hunter | Biotech Hunter